|
[Related PubMed/MEDLINE]
Total Number of Papers: 31
|
|
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
| Page: of |
|
|
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2021 |
Colossolactone-G synergizes the anticancer properties of 5-fluorouracil and gemcitabine against colorectal cancer cells. |
5-FU |
| 2 |
2021 |
Ellagic Acid Resensitizes Gemcitabine-Resistant Bladder Cancer Cells by Inhibiting Epithelial-Mesenchymal Transition and Gemcitabine Transporters. |
EA, EMT |
| 3 |
2021 |
Enhancement of gemcitabine efficacy by K73-03 via epigenetically regulation of miR-421/SPINK1 in gemcitabine resistant pancreatic cancer cells. |
OA, PCa |
| 4 |
2021 |
Mesenchymal Stem/Stromal Cell-Based Delivery: A Rapidly Evolving Strategy for Cancer Therapy. |
5-FC, DOX, GCV, MSC, PTX, TRAIL |
| 5 |
2020 |
The Fas/FasL Signaling Pathway: Its Role in the Metastatic Process and as a Target for Treating Osteosarcoma Lung Metastases. |
FasL, OS |
| 6 |
2019 |
MiR-512-3p regulates malignant tumor behavior and multi-drug resistance in breast cancer cells via targeting Livin. |
BCa, EPB, miRNA |
| 7 |
2019 |
The modulation study of multiple drug resistance in bladder cancer by curcumin and resveratrol. |
ABC, dCK, T24-GCB, TK |
| 8 |
2018 |
Aerosol Gemcitabine after Amputation Inhibits Osteosarcoma Lung Metastases but Not Wound Healing. |
OS |
| 9 |
2018 |
Phosphorylated heat shock protein 27 as a potential biomarker to predict the role of chemotherapy-induced autophagy in osteosarcoma response to therapy. |
OS, pHSP27 |
| 10 |
2018 |
Severe acute toxicity following gemcitabine administration: A report of four cases with cytidine deaminase polymorphisms evaluation. |
--- |
| 11 |
2018 |
Thymoquinone synergizes gemcitabine anti-breast cancer activity via modulating its apoptotic and autophagic activities. |
TQ |
| 12 |
2017 |
Cytolytic virus activation therapy and treatment monitoring for Epstein-Barr virus associated nasopharyngeal carcinoma in a mouse tumor model. |
CLVA, EBV, GCV, NPC, VPA |
| 13 |
2017 |
Drug Loaded Gingival Mesenchymal Stromal Cells (GinPa-MSCs) Inhibit In Vitro Proliferation of Oral Squamous Cell Carcinoma. |
DXR, MSCs, PTX |
| 14 |
2015 |
Gemcitabine-releasing mesenchymal stromal cells inhibit invitro proliferation of human pancreatic carcinoma cells. |
MSCs, pCa |
| 15 |
2014 |
Autophagy and enhanced chemosensitivity in experimental pancreatic cancers induced by noninvasive radiofrequency field treatment. |
PDAC, RF |
| 16 |
2014 |
Autophagy in osteosarcoma. |
OS |
| 17 |
2014 |
Downregulating sCLU enhances the sensitivity of hepatocellular carcinoma cells to gemcitabine by activating the intrinsic apoptosis pathway. |
HCC, sCLU |
| 18 |
2014 |
Participation of the Fas/FasL signaling pathway and the lung microenvironment in the development of osteosarcoma lung metastases. |
--- |
| 19 |
2014 |
Synergistic combination of gemcitabine and dietary molecule induces apoptosis in pancreatic cancer cells and down regulates PKM2 expression. |
BA, CI, PK, TQ |
| 20 |
2012 |
Cytolytic virus activation therapy for Epstein-Barr virus-driven tumors. |
CLVA, EBV, GCV, NPC, VPA |
| 21 |
2011 |
Aerosolized gemcitabine in patients with carcinoma of the lung: feasibility and safety study. |
--- |
| 22 |
2010 |
Aerosol therapy for the treatment of osteosarcoma lung metastases: targeting the Fas/FasL pathway and rationale for the use of gemcitabine. |
FDN, OS |
| 23 |
2008 |
Gemcitabine-induced progressive and sustained tumour response in a patient with multi-drug resistant uterine leiomyosarcoma. |
--- |
| 24 |
2006 |
Toxicity and efficacy of isolated lung perfusion with gemcitabine in a rat model of pulmonary metastases. |
i.v, ILuP |
| 25 |
2005 |
Aerosol gemcitabine inhibits the growth of primary osteosarcoma and osteosarcoma lung metastases. |
OS |
| 26 |
2004 |
Optimization of the schedule of gemcitabine-cisplatin combination as induction regimen for patients with biopsy-proven stage IIIa N2 - stage IIIb non-small-cell lung cancer: a prospective phase-II study. |
CHT, mos, NSCLC, pts |
| 27 |
2003 |
Isolated lung perfusion with gemcitabine in a rat: pharmacokinetics and survival. |
ILuP |
| 28 |
2003 |
Pharmacokinetics after pulmonary artery perfusion with gemcitabine. |
BFO, i.v, ILuP |
| 29 |
2003 |
Systemic capillary leak syndrome resulting from gemcitabine treatment in renal cell carcinoma: a case report. |
RCC, SCLS |
| 30 |
2002 |
Gemcitabine-induced systemic capillary leak syndrome. |
SCLS |
| 31 |
2001 |
Gemcitabine in pre-treated advanced renal carcinoma: a feasibility study. |
PD, SD |
|
A Search Service for Abbreviation / Long Form
